Skip to content

Clinical trials

Kidney Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Country / region: United States Clear all

549 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200120
200221
200320
200424
200525
200634
200727
200823
200924
201014
201111
201214
201310
201419
201512
201613
201726
201813
201911
202020
202112
202215
202315
202413
202518
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed322
Terminated86
Recruiting60
Active, not recruiting42
Unknown status22
Withdrawn9
Not yet recruiting5
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)53
Memorial Sloan Kettering Cancer Center35
M.D. Anderson Cancer Center21
Pfizer15
National Institutes of Health Clinical Center (CC)11
Case Comprehensive Cancer Center9
Dana-Farber Cancer Institute9
Novartis Pharmaceuticals8
Alliance for Clinical Trials in Oncology7
Bristol-Myers Squibb7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms549
Carcinoma, Renal Cell325
Lung Neoplasms91
Breast Neoplasms89
Melanoma78
Ovarian Neoplasms77
Urinary Bladder Neoplasms73
Prostatic Neoplasms70
Neoplasms67
Carcinoma, Non-Small-Cell Lung64

Trials

Showing 1 to 25 of 549. Each trial links to its page on Pharma Observatory.

449 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.